Lindsay Herschfeld, OTR/L in Washington, DC - Occupational Therapist

Lindsay Herschfeld, OTR/L is a Occupational Therapist based in Washington, District Of Columbia. Lindsay Herschfeld is licensed to practice in * (Not Available) (license number ) and her current practice location is 3801 Connecticut Ave Nw # 100, Washington, District Of Columbia. She can be reached at her office (for appointments etc.) via phone at (202) 525-1641.

NPI number for Lindsay Herschfeld is 1437798345 and her current mailing address is 7729 Beech Tree Rd, Bethesda, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1437798345.

Contact Information

	Lindsay Herschfeld, OTR/L
	3801 Connecticut Ave Nw # 100, Washington, DC 20008-4530
	(202) 525-1641
	Not Available

Healthcare Provider's Profile

Full Name	Lindsay Herschfeld
Gender	Female
Speciality	Occupational Therapist
Location	3801 Connecticut Ave Nw # 100, Washington, District Of Columbia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1437798345
Provider Enumeration Date: 12/26/2019
Last Update Date: 12/26/2019

Medical Identifiers

Medical identifiers for Lindsay Herschfeld such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1437798345	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lindsay Herschfeld is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lindsay Herschfeld, OTR/L 7729 Beech Tree Rd, Bethesda, MD 20817-4803 Ph: (301) 518-5055	Lindsay Herschfeld, OTR/L 3801 Connecticut Ave Nw # 100, Washington, DC 20008-4530 Ph: (202) 525-1641

News Archive

Incidence of kidney damage associated with coronary artery bypass surgery has increased significantly

The incidence of kidney damage associated with coronary artery bypass surgery has increased significantly over the past 16 years in the United States, but the rate of death from such damage has decreased significantly during the period, according to a new analysis.

Study finds link between upper GI infections and protein implicated in Parkinson's disease

Acute and chronic infections in a person's upper gastrointestinal tract appear to be linked to Parkinson's disease, say scientists at Georgetown University Medical Center and their collaborators at the National Institutes of Health and other institutions.

World's smallest gastrointestinal videoscope with four-way angulation and NBI

Olympus today introduced the world's smallest gastrointestinal videoscope to offer four-way angulation and Narrow Band Imaging™ (NBI) to detect upper gastrointestinal abnormalities. The super-slim scope is 5.5 mm in diameter at the distal end, as well as the insertion tube, and offers exceptional insertion capability to enhance patient comfort. The scope also features NBI, Olympus' proprietary imaging technology that filters white light to consist of specific wavelength bands enabling enhanced observation of microvessels and subtle changes on the mucosa.

Ironwood, Forest Laboratories announce positive results for linaclotide Phase 3 clinical trials in IBS-C patients

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from the first of two Phase 3 clinical trials assessing the efficacy and safety of the investigational drug, linaclotide, in patients with irritable bowel syndrome with constipation (IBS-C).

Gemcitabine with bevacizumab and radiotherapy safe for pancreatic cancer patients

Treating pancreatic cancer with a combination of chemotherapy, biotherapy and radiotherapy prior to surgery is safe and may be beneficial for patients, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Occupational Therapist in Washington, DC

Miss Samora Casimir, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 443-802-7824
Petra Doyle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 8th St Ne, Suite 301, Washington, DC 20002 Phone: 202-544-5439
Lisa George, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4400 Jenifer St Nw, Suite 280, Washington, DC 20015 Phone: 202-244-8089
Andrea L. Meehan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8000
Samantha Fulp, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 T St Ne, Washington, DC 20002 Phone: 956-278-0770
Tsegie Kassahun, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1818 Newton St Nw, Washington, DC 20010 Phone: 202-328-7400
Dr. Nikia Brocks, OTD,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2411 32nd St Se, Washington, DC 20020 Phone: 202-575-5404 Fax: 301-576-5404

Lindsay Herschfeld, OTR/L - Occupational Therapist in Washington, DC